@misc{ANSESWHATAREVITAMINS,
  author = {ANSES},
  title = {What are vitamins ?},
  url = {https://www.anses.fr/en/content/what-are-vitamins}
}

@misc{Osteomalacie,
  author = {Sant√© sur le net},
  title = {Osteomalacie},
  url = {https://www.sante-sur-le-net.com/maladies/rhumatologie/osteomalacie}
}

@misc{ANSES_VITAMIND,
  author = {ANSES},
  title = {ANSES VITAMIN D},
  url = {https://www.anses.fr/fr/content/vitamine-d-pourquoi-et-comment-assurer-un-apport-suffisant}
}
@article{holickHealthBenefitsVitamin2011,
  title = {Health Benefits of Vitamin {{D}} and Sunlight: A {{D-bate}}},
  shorttitle = {Health Benefits of Vitamin {{D}} and Sunlight},
  author = {Holick, Michael F.},
  year = 2011,
  month = feb,
  journal = {Nature Reviews Endocrinology},
  volume = {7},
  number = {2},
  pages = {73--75},
  copyright = {http://www.springer.com/tdm},
  langid = {english},
}

@article{grantBenefitsRequirementsVitamin,
  title = {Benefits and {{Requirements}} of {{Vitamin D}} for {{Optimal Health}}: {{A Review}}},
  author = {Grant, William B and Holick, Michael F},
  langid = {english},
}

@article{ovesenGeographicalDifferencesVitamin2003,
  title = {Geographical Differences in Vitamin {{D}} Status, with Particular Reference to {{European}} Countries},
  author = {Ovesen, Lars and Andersen, Rikke and Jakobsen, Jette},
  year = 2003,
  month = nov,
  journal = {The Proceedings of the Nutrition Society},
  volume = {62},
  number = {4},
  pages = {813--821},
  issn = {0029-6651},
  doi = {10.1079/PNS2003297},
  abstract = {Vitamin D is produced endogenously when the skin is exposed to sunlight and can be obtained exogenously from a few natural food sources, from food fortification and from supplements. Generally, vitamin D intake is low {$<$} or = 2-3 microg/d in Europe. Casual exposure to sunlight is thought to provide most of the vitamin D requirement of the human population. However, skin synthesis of vitamin D may not compensate for the low nutritional intake in Europe, even in countries with high supplies from food fortification and supplements. For assessment of vitamin D nutritional status the concentration of 25-hydroxyvitamin D (25(OH)D) in serum is considered to be an accurate integrative measure reflecting an individual's dietary intake and cutaneous production. A substantial percentage of the elderly and adolescents in Europe have a low concentration of 25(OH)D; in the elderly this percentage ranges from approximately 10 in the Nordic countries to approximately 40 in France. Low vitamin D status seems to be aggravated by disease and immobility, and by a low frequency of supplement use.},
  langid = {english},
  pmid = {15018480},
}

@article{zittermannEstimatedBenefitsVitamin2010,
  title = {The Estimated Benefits of Vitamin {{D}} for {{Germany}}},
  author = {Zittermann, A.},
  year = 2010,
  journal = {Molecular Nutrition \& Food Research},
  volume = {54},
  number = {8},
  pages = {1164--1171},
  issn = {1613-4133},
  doi = {10.1002/mnfr.200900494},
  abstract = {This article gives an overview of the vitamin D status in Germany, provides evidence for an independent association of vitamin D deficiency with various chronic diseases, and discusses preventive measures for improving vitamin D status in Germany. The prevalence of vitamin D insufficiency is 40--45\% in the general German population. An additional 15--30\% are vitamin D deficient. Vitamin D can prevent falls and osteoporotic fractures in older people. There is also accumulating evidence that vitamin D may prevent excess mortality and may probably prevent some chronic diseases that occur in early life such as type 1 diabetes and multiple sclerosis. Adherence to present sun safety policy (avoidance of the sun between 11 am and 3 pm) and dietary recommendations (5--10 {$\mu$}g daily for adults) would, however, definitively lead to vitamin D deficiency. The estimated cost saving effect of improving vitamin D status in Germany might be up to 37.5 billion \texteuro{} annually. It should be the goal of nutrition and medical societies to erase vitamin D deficiency in Germany within the next 5--10 years. To achieve this goal, the daily production of at least 25 {$\mu$}g of vitamin D in the skin or an equivalent oral intake should be guaranteed.},
  copyright = {Copyright \copyright{} 2010 WILEY-VCH Verlag GmbH \& Co. KGaA, Weinheim},
  langid = {english},
  keywords = {Costs,Mortality,Survival,Ultraviolet radiation,Vitamin D},
}

@article{holickEvidencebasedDbateHealth2012,
  title = {Evidence-Based {{D-bate}} on Health Benefits of Vitamin {{D}} Revisited},
  author = {Holick, Michael F},
  year = 2012,
  month = apr,
  journal = {Dermato-Endocrinology},
  volume = {4},
  number = {2},
  pages = {183--190},
  issn = {1938-1980},
  doi = {10.4161/derm.20015},
  langid = {english},
}

@article{lagowskaRelationshipVitaminStatus2018,
  title = {The {{Relationship}} between {{Vitamin D Status}} and the {{Menstrual Cycle}} in {{Young Women}}: {{A Preliminary Study}}},
  shorttitle = {The {{Relationship}} between {{Vitamin D Status}} and the {{Menstrual Cycle}} in {{Young Women}}},
  author = {{\L}agowska, Karolina},
  year = 2018,
  month = nov,
  journal = {Nutrients},
  volume = {10},
  number = {11},
  pages = {1729},
  publisher = {Multidisciplinary Digital Publishing Institute},
  issn = {2072-6643},
  doi = {10.3390/nu10111729},
  abstract = {Background: The aim of this study was to evaluate serum vitamin D levels and to compare these with the menstrual cycle in young women with different body weights. Methods: Eighty-four students were recruited into the study of which 77 remained at the study's completion. Women were assigned to one of two subgroups, according to their 25-hydroxy vitamin D test level [25(OH)D] in which 60 women had low 25(OH)D levels (LD {$<$} 30 ng/mL) and 17 had normal levels (ND {$>$} 30 ng/mL {$\leq$} 80 ng/mL). Results: In the LD group, 40\% of participants reported having long cycles, 27\% were classified as having oligomenorrhoea, and 13\% as having amenorrhoea. In the ND group, only 12\% reported menstrual cycle disorders, 6\% had oligomenorrhoea, and 6\% had amenorrhoea. Women who did not meet the recommended level of 30 ng/mL of 25(OH)D had almost five times the odds of having menstrual cycle disorders as women who were above the recommended vitamin D level. Conclusion: A relationship was demonstrated between the frequency of menstrual disorders and low levels of vitamin D. Supplementation is necessary in women with low levels of vitamin D in order to compensate for this deficiency and to assess its effect in regulating menstrual disorders.},
  copyright = {http://creativecommons.org/licenses/by/3.0/},
  langid = {english},
  keywords = {25(OH)D,menstrual cycle,nutritional status,vitamin D},
}

@article{krishnanPotentialTherapeuticBenefits2012,
  title = {The Potential Therapeutic Benefits of Vitamin {{D}} in the Treatment of Estrogen Receptor Positive Breast Cancer},
  author = {Krishnan, Aruna V. and Swami, Srilatha and Feldman, David},
  year = 2012,
  month = sep,
  journal = {Steroids},
  volume = {77},
  number = {11},
  pages = {1107--1112},
  issn = {0039-128X},
  doi = {10.1016/j.steroids.2012.06.005},
  abstract = {Calcitriol (1,25-dihydroxyvitamin D3), the hormonally active form of vitamin D, inhibits the growth of many malignant cells including breast cancer (BCa) cells. The mechanisms of calcitriol anticancer actions include cell cycle arrest, stimulation of apoptosis and inhibition of invasion, metastasis and angiogenesis. In addition we have discovered new pathways of calcitriol action that are especially relevant in inhibiting the growth of estrogen receptor positive (ER+) BCa cells. Calcitriol suppresses COX-2 expression and increases that of 15-PGDH thereby reducing the levels of inflammatory prostaglandins (PGs). Our in vitro and in vivo studies show that calcitriol decreases the expression of aromatase, the enzyme that catalyzes estrogen synthesis selectively in BCa cells and in the mammary adipose tissue surrounding BCa, by a direct repression of aromatase transcription via promoter II as well as an indirect effect due to the reduction in the levels of PGs, which are major stimulator of aromatase transcription through promoter II. Calcitriol down-regulates the expression of ER{$\alpha$} and thereby attenuates estrogen signaling in BCa cells including the proliferative stimulus provided by estrogens. Thus the inhibition of estrogen synthesis and signaling by calcitriol and its anti-inflammatory actions will play an important role in inhibiting ER+BCa. We hypothesize that dietary vitamin D would exhibit similar anticancer activity due to the presence of the enzyme 25-hydroxyvitamin d-1{$\alpha$}-hydroxylase (CYP27B1) in breast cells ensuring conversion of circulating 25-hydroxyvitamin D to calcitriol locally within the breast micro-environment where it can act in a paracrine manner to inhibit BCa growth. Cell culture and in vivo data in mice strongly suggest that calcitriol and dietary vitamin D would play a beneficial role in the prevention and/or treatment of ER+BCa in women.},
  keywords = {Aromatase,Breast cancer,Calcitriol,Dietary vitamin D,Estrogen receptor,Prostaglandins},
}

@misc{Phosphorus,
  author = {Talon Fitness},
  howpublished = {Youtube},
  title = {Phosphorus - The True Nutrients},
  year = {2024},
  url = {https://www.youtube.com/watch?v=9cW6F0hvvs0}
}

@misc{BloodCoagulation,
  title = {Blood coagulation},
  url = {https://ec.europa.eu/health/scientific_committees/opinions_layman/en/non-human-primates/glossary/abc/blood-clot.htm}
}

@misc{pharmaciepolygone,
  author = {Pharmacie du Polygone},
  title = {Vitamines D2 et D3 : Comment faire la difference ?},
  year = {},
  url = {https://www.pharmaciepolygone.com/fr/page/vitamines-d2-et-d3-comment-faire-la-difference}
}

@misc{VeganPratique,
  author = {Vegan pratique},
  title = {La vitamine D},
  url = {https://vegan-pratique.fr/conseils-nutrition-vegetalienne/la-vitamine-d/}
}

@article{borelVitaminBioavailabilityState2015,
  title = {Vitamin {{D}} Bioavailability: State of the Art},
  shorttitle = {Vitamin {{D}} Bioavailability},
  author = {Borel, P. and Caillaud, D. and Cano, N. J.},
  year = 2015,
  journal = {Critical Reviews in Food Science and Nutrition},
  volume = {55},
  number = {9},
  pages = {1193--1205},
  issn = {1549-7852},
  doi = {10.1080/10408398.2012.688897},
  abstract = {There has been renewed interest in vitamin D since numerous recent studies have suggested that besides its well-established roles in bone metabolism and immunity, vitamin D status is inversely associated with the incidence of several diseases, e.g., cancers, cardio-vascular diseases, and neurodegenerative diseases. Surprisingly, there is very little data on factors that affect absorption of this fat-soluble vitamin, although it is acknowledged that dietary vitamin D could help to fight against the subdeficient vitamin D status that is common in several populations. This review describes the state of the art concerning the fate of vitamin D in the human upper gastrointestinal tract and on the factors assumed to affect its absorption efficiency. The main conclusions are: (i) ergocalciferol (vitamin D2), the form mostly used in supplements and fortified foods, is apparently absorbed with similar efficiency to cholecalciferol (vitamin D3, the main dietary form), (ii) 25-hydroxyvitamin D (25OHD), the metabolite produced in the liver, and which can be found in foods, is better absorbed than the nonhydroxy vitamin D forms cholecalciferol and ergocalciferol, (iii) the amount of fat with which vitamin D is ingested does not seem to significantly modify the bioavailability of vitamin D3, (iv) the food matrix has apparently little effect on vitamin D bioavailability, (v) sucrose polyesters (Olestra) and tetrahydrolipstatin (orlistat) probably diminish vitamin D absorption, and (vi) there is apparently no effect of aging on vitamin D absorption efficiency. We also find that there is insufficient, or even no data on the following factors suspected of affecting vitamin D bioavailability: (i) effect of type and amount of dietary fiber, (ii) effect of vitamin D status, and (iii) effect of genetic variation in proteins involved in its intestinal absorption. In conclusion, further studies are needed to improve our knowledge of factors affecting vitamin D absorption efficiency. Clinical studies with labeled vitamin D, e.g., deuterated or (13)C, are needed to accurately and definitively assess the effect of various factors on its bioavailability.},
  langid = {english},
  pmid = {24915331},
  keywords = {25-hydroxyvitamin D,absorption,Aging,bioaccessibility,Biological Availability,Cholecalciferol,Dietary Supplements,ergocalciferol,Ergocalciferols,Fatty Acids,Food Fortified,Humans,Intestinal Absorption,intestine,Lactones,Orlistat,Risk Factors,Sucrose,Vitamin D},
}

@article{zhuVitaminD3Marine2025,
  title = {Vitamin {{D3}} and Marine {$\omega$}-3 Fatty Acids Supplementation and Leukocyte Telomere Length: 4-Year Findings from the {{VITamin D}} and {{OmegA-3 TriaL}} ({{VITAL}}) Randomized Controlled Trial},
  shorttitle = {Vitamin {{D3}} and Marine {$\omega$}-3 Fatty Acids Supplementation and Leukocyte Telomere Length},
  author = {Zhu, Haidong and Manson, JoAnn E and Cook, Nancy R and Bekele, Bayu B and Chen, Li and Kane, Kevin J and Huang, Ying and Li, Wenjun and Christen, William and Lee, I-Min and Dong, Yanbin},
  year = 2025,
  month = jul,
  journal = {The American Journal of Clinical Nutrition},
  volume = {122},
  number = {1},
  pages = {39--47},
  issn = {0002-9165},
  doi = {10.1016/j.ajcnut.2025.05.003},
  abstract = {Background Limited studies suggest that vitamin D or omega 3 fatty acids (n-3 FAs) supplementation may be beneficial for telomere maintenance, however, evidence from large randomized clinical trial is lacking. Objective We aimed to determine whether vitamin D or n-3 FAs supplementation reduce leukocyte telomere length (LTL) attrition over time by leveraging the VITamin D and OmegA-3 TriaL (VITAL) trial. Methods VITAL is a large, randomized, double-blind, placebo-controlled tr ial with a 2 x 2 factorial design of vitamin D3 (2,000 IU/day) and marine n-3 FAs (1 g/day) supplements for 5 years among a representative sample of 25,871 US females {$\geq$}55 and males {$\geq$}50 years of age. The VITAL Telomere study (NCT04386577) included 1054 participants who were evaluated in person at the Harvard Clinical and Translational Science Center. LTL was determined by the Absolute Human Telomere Length Quantification quantitative Polymerase Chain Reaction (PCR) method at baseline, Year 2, and Year 4. The pre-specified primary outcome measures were changes in LTL between baseline, Year 2 and Year 4. Analyses of intervention effect used mixed-effects linear regression models. Results LTL was measured in a total of 2,571 samples from the 1031 participants at baseline, year 2, and year 4. Compared to placebo, vitamin D3 supplementation significantly decreased LTL attrition by 0.14 kilo base pairs (kb) (95\%CI: 0.007, 0.27) over 4 years (p = 0.039). Overall trend analysis showed that the vitamin D3 supplementation group had LTLs that were about 0.035 kb higher per year of follow-up compared to placebo group (95\%CI: 0.002, 0.07, p=0.037). Marine n-3 FAs supplementation had no significant effect on LTL at either year 2 or year 4. Conclusion 4-years of supplementation with 2000 IU/day vitamin D3 reduced telomere attrition by 140 bp, suggesting that vitamin D3 daily supplementation with or without n-3 FAs might have a role in counteracting telomere erosion or cell senescence.},
  keywords = {aging,marine n-3 fatty acids,telomere length,vitamin D},
}

@misc{NHI,
  author = {NHI},
  title = {Vitamin D supplements may slow cellular aging},
  url = {https://www.nhlbi.nih.gov/news/2025/vitamin-d-supplements-may-slow-cellular-aging}
}


@misc{Telomere,
  title = {Telomere},
  url = {https://www.genome.gov/genetics-glossary/Telomere},
}